<DOC>
	<DOCNO>NCT01581944</DOCNO>
	<brief_summary>Fibroids common West Indian population ( 30-40 % reproductive woman ) .Fibroids benign growth womb uterus order preserve fertility woman , require operation call myomectomy shell fibroid . This procedure associate large blood loss . In current practice obstetrician use gonadotropin release hormone agonist prior operation reduce blood loss . Gonadotropin release hormone agonist use current gynaecological practice treat woman heavy period . In study investigator randomise woman either 2 3 dos gonadotropin agonist prior operation treatment . The intraoperative blood loss measure . The study hypothesis : To determine whether administration gonadotropin release hormone agonist prior myomectomy reduces intraoperative blood loss .</brief_summary>
	<brief_title>Gonadotropin-releasing Hormone Agonist Prior Myomectomy</brief_title>
	<detailed_description>Variables note preoperatively : - Age - Parity - Ethnicity - Ultrasound finding Variables note intra-operatively : - Size large fibroid - Estimated blood loss</detailed_description>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Goserelin</mesh_term>
	<criteria>Women age 20 45 Symptomatic fibroid Presence regular menstrual cycle Ultrasound confirmation fibroid Normal cervical smear Pregnancy The length hospital stay calculate number day date date discharge Presence endometriosis Previous myomectomy Ovarian , uterine cervical malignancy female factor subfertility</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>myomectomy</keyword>
	<keyword>GnRH</keyword>
	<keyword>blood loss</keyword>
</DOC>